Aetna International Announces Product Upgrades And Updates To COVID-19 Coverage Featured
- Written by iPMI Magazine
- font size decrease font size increase font size
In The iPMI Picture: Damian Lenihan, Executive Director Europe at Aetna International.
Aetna International, a leading provider of global health benefits, has announced updates to its cover for communicable diseases, including COVID-19, all aimed at supporting the physical health of its members in an ever-evolving international landscape.
The changes to its Summit plans will offer better flexibility for business clients, allowing them to tailor coverage based on local market and member needs. The updates will allow members to access a COVID-19 test if they have no symptoms. This type of testing could help businesses to mitigate the risk of transmission.
After a qualifying period, individual members with Pioneer 2500 to 5000+ plans will benefit from outpatient tests and diagnostic procedures for communicable diseases (including COVID-19) when they do not have symptoms.
Additionally, to further support members’ physical health during this challenging time, Aetna International is also adding vaccinations as a stand-alone benefit to its range of COVID-19 cover for both Summit and Pioneer plans.
Damian Lenihan, Executive Director Europe at Aetna International said: “Our aim is to support businesses and individuals by ensuring they have access to cover that is tailored to today’s unique challenges. Countries around the world are facing a range of infection rates and restrictions and are tackling these with vastly different healthcare systems and strategies.”
“This means our cover needs to be flexible and adaptable as we all continue to navigate the new routines created by the pandemic. We want to ensure businesses and their employees have access to appropriate COVID-19 testing, whenever they need it and wherever they are.”
Recognising the ongoing impact of the pandemic, the temporary extension of COVID-19 testing coverage will continue. Up to and including 31 March 2021, Aetna International members will be covered for one test per calendar month if they are asymptomatic and classified as high-risk* – as referred by a medical practitioner and when testing takes place in an appropriate medical facility.
While reimbursements for COVID-19 testing won’t be offered as standard for all policies, plan sponsors will have the flexibility to add this cover to Summit plans, without increasing premiums for those who do not want or need this benefit (for example, in areas where free local testing is already available.
*Refer to aetnainternational.com for full details
Related items
- GBG Introduces New Brand and Website
- International Private Medical Insurance Magazine Provider Network Directory January 2022
- Global Ventures Attracts New Investment For Its Second Fund From Bupa Arabia
- International Private Medical Insurance Magazine Provider Network Directory December 2021
- Will Bupa And DNI Now Compete In Several Countries Where Generali And Generali Employee Benefits Are Both In Business, Or Just The Middle East, Or Just The UAE?
- AXA – Global Healthcare Appoints Andy O’Cain As Global Head Of Distribution
- The Death Of The Credit Standard In IPMI & Travel Insurance
- DIOT-LSN And SIACI SAINT HONORE Finalize Their Merger And Create A Leading Independent European Insurance Broker
- Expatriate Group Adds Free Upgrades To Corporate iPMI Plans For All New And Existing Policyholders
- BLACK FRIDAY: Save Up To 33% When You Purchase International Health Insurance (IPMI) 2021 Report
Latest from iPMI Magazine
- GBG Introduces New Brand and Website
- IMG Welcomes Dina Tarantola-Froner As Chief Underwriting Officer
- AXA Completes Sale Of AXA Bank Belgium
- International Private Medical Insurance Magazine Provider Network Directory January 2022
- iPMI Magazine Speaks With Angela Smith, Head Of Proposition Development, Charles Taylor Assistance